STAAR Surgical (STAA) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
STAAR Surgical Reports Second Quarter 2016 Results
August 3, 2016 4:01 PM EDTMONROVIA, Calif., Aug. 3, 2016 /PRNewswire/ --Â STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye today reported financial results for the second quarter ended July 1, 2016.
Second Quarter 2016 Overview
Record Quarterly Net Sales of $21.0 Million Up 12% from the Prior Year Quarter Worldwide ICL Sales Up 26% and Units Up 18% from the Prior Year Quarter Worldwide IOL Sales Down 3% and Units Down 15% from the Prior Year Quarter Gross Margin Improved to 69.7% of... More